Allianz Asset Management GmbH Buys 29,256 Shares of Globe Life Inc. $GL

Allianz Asset Management GmbH lifted its stake in Globe Life Inc. (NYSE:GL) by 55.2% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 82,263 shares of the company’s stock after buying an additional 29,256 shares during the period. Allianz Asset Management GmbH’s holdings in Globe Life were worth $11,761,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Invesco Ltd. grew its holdings in shares of Globe Life by 3.9% in the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after purchasing an additional 147,644 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Globe Life by 2.9% in the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after acquiring an additional 76,995 shares during the period. AQR Capital Management LLC raised its stake in shares of Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after acquiring an additional 696,548 shares during the last quarter. Norges Bank purchased a new stake in shares of Globe Life during the second quarter worth about $157,722,000. Finally, Bank of New York Mellon Corp grew its stake in shares of Globe Life by 3.6% in the second quarter. Bank of New York Mellon Corp now owns 1,248,025 shares of the company’s stock worth $155,117,000 after purchasing an additional 43,095 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 9,379 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the sale, the chief executive officer owned 35,868 shares of the company’s stock, valued at $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.51% of the stock is currently owned by insiders.

Globe Life Stock Performance

Globe Life stock opened at $146.62 on Monday. Globe Life Inc. has a twelve month low of $109.38 and a twelve month high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $11.67 billion, a P/E ratio of 10.41 and a beta of 0.47. The stock’s 50 day moving average is $139.38 and its 200 day moving average is $138.17.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the company posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have commented on GL. Weiss Ratings lowered Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Piper Sandler reaffirmed an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley reiterated an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Truist Financial lifted their price objective on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday. Finally, Wells Fargo & Company decreased their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $171.00.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.